GRB2 and lung carcinoma: Mutant EGFR pulldowns identified MAPK adaptors GRB2 and SHC1 as well as ERRFI and UBS3B tyrosine phosphatase, all consistent with our results described in the lung cancer cell lines harboring mutant EGFR.